Adverum Biotechnologies (ADVM) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts ADVM Hot Sheet
Join SI Premium – FREE
Adverum Biotechnologies (NASDAQ: ADVM) reported Q4 EPS of ($0.29), in-line with the analyst estimate of ($0.29).
For earnings history and earnings-related data on Adverum Biotechnologies (ADVM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Applied Industrial Technologies (AIT) Tops Q3 EPS by 8c; Updates outlook
- MarineMax (HZO) Misses Q2 EPS by 48c, provides guidance
- Harley-Davidson (HOG) Tops Q1 EPS by 20c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
